Literature DB >> 29016530

REABSORPTION OF ACQUIRED VITELLIFORM LESIONS IN VITREOMACULAR DISORDERS AFTER VITRECTOMY.

Giulio Bamonte1, Andrea Appeltans1, Maria Vittoria Cicinelli2, Giuseppe Querques2.   

Abstract

PURPOSE: To describe cases of reabsorption of subretinal acquired vitelliform material (acquired vitelliform lesion [AVL]) associated with vitreomacular disorders after 25-gauge pars plana vitrectomy and peeling of internal limiting membrane.
METHODS: Data of consecutive patients who underwent 25-gauge transconjunctival pars plana vitrectomy for vitreomacular disorders at the Department of Ophthalmology of the University Hospital of Brussels (Belgium) were collected. Patients featuring AVL on fundus examination or on spectral domain optical coherence tomography were recruited. Patients were followed up for 12 months after surgery.
RESULTS: Four eyes of three consecutive white patients presenting AVL were included. Three cases were affected by macular pucker, whereas one case featured vitreomacular traction syndrome. Progressive flattening of the AVL after surgery was observed in three eyes of three patients. One eye did not show any resorption of the submacular accumulation. In two eyes, atrophy of the retinal pigment epithelium and the outer retinal layers was observed along with resolution of the AVL, with significant worsening of visual acuity postoperatively.
CONCLUSION: The outcome of surgery in cases of submacular AVL associated with vitreomacular interface syndromes could be heterogeneous and may depend on the duration of the disease and baseline optical coherence tomography characteristics of the lipofuscin accumulation.

Entities:  

Mesh:

Year:  2020        PMID: 29016530     DOI: 10.1097/ICB.0000000000000635

Source DB:  PubMed          Journal:  Retin Cases Brief Rep        ISSN: 1935-1089


  1 in total

1.  Spontaneous Closure of the Macular Hole in a Patient with Acquired Vitelliform Lesion.

Authors:  Masanori Fukumoto; Shou Oosuka; Takaki Sato; Teruyo Kida; Tsunehiko Ikeda
Journal:  Case Rep Ophthalmol       Date:  2020-01-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.